Kenneth M Meyers

Title: Innovations by Kenneth M Meyers

Introduction

Kenneth M Meyers is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific protein interactions.

Latest Patents

Kenneth holds three patents, with his latest innovations focusing on WDR5 inhibitors and modulators. One of his patents describes isoquinolinone compounds and derivatives that inhibit WDR5 and associated protein-protein interactions. These compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation. Another patent details imino-azacycle-benzamide compounds that also inhibit WDR5 and associated protein-protein interactions. This patent includes pharmaceutical compositions featuring these compounds and methods for using them to treat various disorders.

Career Highlights

Kenneth is affiliated with Vanderbilt University, where he continues to advance research in his field. His work has garnered attention for its potential applications in treating serious health conditions.

Collaborations

Some of his notable coworkers include Joseph R Alvarado and Shaun R Stauffer, who contribute to the collaborative research environment at Vanderbilt University.

Conclusion

Kenneth M Meyers is a distinguished inventor whose work on WDR5 inhibitors has the potential to impact cancer treatment significantly. His contributions to pharmaceutical research exemplify the importance of innovation in addressing complex health challenges.